A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. Our execution strategy is built on innovative R&D, clinical and regulatory pathway expansion and customer centric sales performance. AngioDynamics was founded in Queensbury, N.Y., U.S., in 1988 and began manufacturing and shipping product in the early 1990s. The Company is headquartered in Latham, N.Y., with manufacturing primarily out of the Queensbury facility. Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 307M | 292M | 304M | 339M | 316M | 291M |
| Net Income | -28M | -34M | -184M | -52M | -27M | -32M |
| EPS | $-0.67 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 |
| Free Cash Flow | -9.3M | -15M | -31M | -3.7M | -11M | 19M |
| ROIC | -27.6% | -17.2% | -89.7% | -12.2% | -5.9% | -7.2% |
| Gross Margin | 54.6% | 53.9% | 50.9% | 51.4% | 52.4% | 53.9% |
| Debt/Equity | 0.00 | 0.03 | 0.00 | 0.13 | 0.06 | 0.05 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -33M | -40M | -192M | -51M | -28M | -35M |
| Operating Margin | -10.6% | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% |
| ROE | -15.7% | -17.5% | -89.7% | -13.9% | -6.3% | -7.2% |
| Shares Outstanding | 41M | 41M | 40M | 39M | 39M | 38M |
ANGIODYNAMICS INC passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 52.5%. At current prices, the estimated annualized return to fair value is -28.3%.
ANGIODYNAMICS INC (ANGO) has a 5-year average return on invested capital (ROIC) of -26.4%. This is below average and may indicate limited pricing power.
ANGIODYNAMICS INC (ANGO) has a market capitalization of $432M. It is classified as a small-cap stock.
ANGIODYNAMICS INC (ANGO) does not currently pay a regular dividend.
ANGIODYNAMICS INC (ANGO) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
ANGIODYNAMICS INC (ANGO) reported annual revenue of $292 million in its most recent fiscal year, based on SEC EDGAR filings.
ANGIODYNAMICS INC (ANGO) has a net profit margin of -11.6%. The company is currently unprofitable.
ANGIODYNAMICS INC (ANGO) generated $-15 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
ANGIODYNAMICS INC (ANGO) has a debt-to-equity ratio of 0.03. This indicates a conservatively financed balance sheet.
ANGIODYNAMICS INC (ANGO) reported earnings per share (EPS) of $-0.83 in its most recent fiscal year.
ANGIODYNAMICS INC (ANGO) has a return on equity (ROE) of -17.5%. A negative ROE may indicate losses or negative equity.
ANGIODYNAMICS INC (ANGO) has a 5-year average gross margin of 52.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for ANGIODYNAMICS INC (ANGO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ANGIODYNAMICS INC (ANGO) has a book value per share of $4.47, based on its most recent annual SEC filing.